By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a




Company News
Cellectis (ALCLS) R&D / Analyst Day 6/25/2014 11:20:05 AM
Cellectis (ALCLS)’ UCART19 Receives Advanced-Therapy Medicinal Product Classification From European Medicines Agency 6/23/2014 11:07:03 AM
Cellectis (ALCLS) To Participate In The Piper Jaffray GenomeRx Symposium On June 23, 2014 6/19/2014 10:30:13 AM
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/18/2014 6:22:51 AM
Cellectis Enters Into An Agreement With CELLforCURE For The cGMP Manufacturing Of Allogeneic CART Cells 6/9/2014 11:10:44 AM
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014 12:47:32 PM
Cellectis And Thermo Fisher Scientific (TMO) Enter Into Agreements On TALEN™, A Leading Gene Editing Technology 6/5/2014 9:09:31 AM
Cellectis Will Be Present At The American Society of Clinical Oncology Annual Meeting 5/27/2014 11:10:23 AM
Cellectis Announces The Closing Of €20.5 Million Share Capital Increase Subscribed On March 24, 2014 By U.S. Biotechnology Specialist Institutional Investors 4/1/2014 6:56:05 AM
Cellectis, Servier Forge Leukemia, Solid Tumors Pact To Battle With Novartis AG (NVS) And Newbie Juno Therapeutics 2/18/2014 7:39:15 AM